ACCOLADE PARTNERS VI |
0 |
-306,108 |
0 |
ACCOLADE PARTNERS VII |
1,252 |
-94,400 |
1,252 |
AH ANDRESSEN HOROWITZ LSV |
0 |
-10,709 |
0 |
BIOPHARMA CREDIT IV |
931,784 |
931,784 |
931,784 |
BREP VII |
1,147,390 |
1,838,740 |
1,147,390 |
CARLYE REALTY FOREIGN INVESTORS VII-A LP |
153,687 |
1,866,361 |
153,687 |
DEERFIELD HEALTHCARE INNOVATIONS FUND LP |
0 |
-181,273 |
0 |
DEERFIELD RE HOLDINGS IV LP |
0 |
155 |
0 |
DEERFIELD PRIVATE DESIGN FUND IV LP |
0 |
326,803 |
0 |
EDGBASTON ASIAN EQUITY TRUST FD |
0 |
3,007,906 |
0 |
INTERNATIONAL EQUITY LONG-ONLY FUND LP |
0 |
-182,207 |
0 |
GENERAL ATLANTIC |
418,947 |
5,196,900 |
418,947 |
GREEN EQUITY INVESTORS VII |
0 |
-41,511 |
0 |
HIGHCLERE INTERNATIONAL INVESTORS SMID FUND |
0 |
1,196,602 |
0 |
HIGHFIELDS CAPITAL IV LP |
0 |
88,194 |
0 |
INSIGHT VENTURE PARTNERS (CAYMAN) IX, LP |
0 |
-520,488 |
0 |
INSIGHT VENTURE PARTNERS (CAYMAN) X, LP |
0 |
-263,133 |
0 |
INSIGHT VENTURE PARTNERS (CAYMAN) XI, LP |
0 |
180 |
0 |
INSTITUTIONAL VENTURE PARTNERS XVI |
0 |
-191,156 |
0 |
IP IV AIV LP (MHR) |
0 |
271,087 |
0 |
IP IV AIV LP - YOST UNBLOCKED SERIES (MHR) |
0 |
272,755 |
0 |
LEGACY VENTURE VIII LLC |
0 |
-318,900 |
0 |
LEGACY VENTURE IX LLC |
0 |
-130,083 |
0 |
MENLO SPECIAL OPPORTUNITIES FUND |
0 |
-72,365 |
0 |
MHR INSTITUTIONAL PARTNERS IV LP |
0 |
40,044 |
0 |
RAINE PARTNERS II LP |
0 |
-81,847 |
0 |
RAINE PARTNERS II - AIV 2 LP |
0 |
79,615 |
0 |
RAINE PARTNERS II (CAYMAN) LP |
0 |
-75,636 |
0 |
RAINE PARTNERS II (CAYMAN) - AIV 2 LP |
0 |
-52 |
0 |
SILCHESTER INTERNATIONAL INVESTORS |
0 |
1,043,514 |
0 |
THE HURON FUND IV LP |
0 |
-429,428 |
0 |
THE SANDERSON INTERNATIONAL |
0 |
706,351 |
0 |
WALTON STREET REAL ESTATE FUND VII-Q LP |
1,940,082 |
2,163 |
1,940,082 |
WALTON STREET REAL ESTATE FUND VIII LP |
0 |
-81,840 |
0 |
MISCELLANEOUS INCOME |
1 |
0 |
1 |
REBATE INCOME |
28,971 |
28,971 |
28,971 |
UBTI FROM PARTNERSHIP K-1S |
2,254,631 |
|
2,254,631 |
LESS: K-1 UBTI REFLECTED FOR NET INV INC BUT NOT FOR BOOK |
-2,254,631 |
|
-2,254,631 |